Terms ending in 2032
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,133,187 | Serine/Threonine Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,561,214 | Method of Treatment Using Inhibitors of Mitosis In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,878,997 | Pyrrolidinyl Urea, Pyrrolidinyl Thiourea and Pyrrolidinyl Guanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 10,323,022 | Pyrrolidinyl Urea, Pyrrolidinyl Thiourea and Pyrrolidinyl Guanidine Compounds as Trka Kinase Inhibitors In force · Low confidence | Array Biopharma Inc. | In force | Low confidence | |
| US 10,851,080 | Methods of Treatment Using Pyrrolidinyl Urea, Thiourea, Guanidine and Cyanoguanidine Compounds In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,562,055 | Pyrrolidinyl Urea, Pyrrolidinyl Thiourea and Pyrrolidinyl Guanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,828,360 | Pyrrolidinyl Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,896,435 | N-Pyrrolidinyl,n'-Pyrazolyl-Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,168,254 | Polymorphs of ARRY-380, a Selective Her 2 Inhibitor and Pharmaceutical Compositions Containing Them In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,457,093 | Solid Dispersions of a ERB2 (HER2) Inhibitor In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| 9 more term ends in 2032 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.